|
gptkbp:instanceOf
|
gptkb:chemical_compound
opioid
|
|
gptkbp:ATCCode
|
V03AB15
|
|
gptkbp:binding_affinity
|
high affinity for mu, kappa, and delta opioid receptors
|
|
gptkbp:brand
|
Revivon
|
|
gptkbp:CASNumber
|
14357-78-9
|
|
gptkbp:chemicalFormula
|
C26H29NO4
|
|
gptkbp:compatibleWith
|
human medicine
|
|
gptkbp:countryOfOrigin
|
gptkb:New_Zealand
gptkb:South_Africa
gptkb:United_Kingdom
|
|
gptkbp:developedBy
|
gptkb:veterinary_medicine
|
|
gptkbp:effect
|
reverses opioid-induced respiratory depression
|
|
gptkbp:enemyOf
|
gptkb:opioid_receptors
gptkb:etorphine
gptkb:carfentanil
|
|
gptkbp:hasSMILES
|
CC1=CC2=C(C=C1)C3CC4C5=CC=CC=C5N(C4CC3C2)CCCOC6=CC=CO6
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
diprenorphine
|
|
gptkbp:IUPACName
|
7,8-dihydro-7α-[1-(3-furyl)propyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine-3,6-diol
|
|
gptkbp:legalStatus
|
veterinary use only
|
|
gptkbp:molecularWeight
|
419.51 g/mol
|
|
gptkbp:PubChem_CID
|
gptkb:CHEMBL2104347
5360515
4515027
|
|
gptkbp:relatedTo
|
gptkb:etorphine
gptkb:carfentanil
|
|
gptkbp:routeOfAdministration
|
intramuscular
intravenous
|
|
gptkbp:sideEffect
|
nausea
vomiting
hypertension
tachycardia
agitation
|
|
gptkbp:UNII
|
6V9V7G2F3B
|
|
gptkbp:usedFor
|
opioid
reversal of etorphine and carfentanil
|
|
gptkbp:bfsParent
|
gptkb:etorphine
|
|
gptkbp:bfsLayer
|
7
|